| reactome |
B_2_1 |
R-HSA-179419 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint |
2/17 |
73/11146 |
0.0053995538152084 |
0.0236935645025563 |
0.00984050656031695 |
PSMA5/PSMB3 |
2 |
| reactome |
B_2_1 |
R-HSA-1234174 |
Cellular response to hypoxia |
2/17 |
75/11146 |
0.00569138978105445 |
0.0241232686527144 |
0.0100189730172391 |
PSMA5/PSMB3 |
2 |
| reactome |
B_2_1 |
R-HSA-176409 |
APC/C:Cdc20 mediated degradation of mitotic proteins |
2/17 |
75/11146 |
0.00569138978105445 |
0.0241232686527144 |
0.0100189730172391 |
PSMA5/PSMB3 |
2 |
| GO |
B_2_1 |
GO:0097250 |
mitochondrial respirasome assembly |
2/19 |
114/18986 |
0.00571671014534254 |
0.0350624888914343 |
0.0216633226560349 |
NDUFAB1/NDUFB3 |
2 |
| reactome |
B_2_1 |
R-HSA-8951664 |
Neddylation |
3/17 |
246/11146 |
0.00574363539350342 |
0.0241232686527144 |
0.0100189730172391 |
PSMA5/PSMB3/UFD1 |
3 |
| reactome |
B_2_1 |
R-HSA-176814 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins |
2/17 |
76/11146 |
0.00583998383807083 |
0.0241824682872229 |
0.010043560047683 |
PSMA5/PSMB3 |
2 |
| WikiPathways |
B_2_1 |
WP5124 |
Alzheimer 39 s disease |
3/13 |
263/8836 |
0.00597485578338494 |
0.0204635646752959 |
0.00994181279771461 |
HSD17B10/PSMA5/PSMB3 |
3 |
| reactome |
B_2_1 |
R-HSA-8852276 |
The role of GTSE1 in G2/M progression after G2 checkpoint |
2/17 |
77/11146 |
0.00599035511759391 |
0.0244606167301751 |
0.0101590817783756 |
PSMA5/PSMB3 |
2 |
| reactome |
B_2_1 |
R-HSA-5619084 |
ABC transporter disorders |
2/17 |
78/11146 |
0.00614249851182471 |
0.0247382816777598 |
0.0102744027018265 |
PSMA5/PSMB3 |
2 |
| WikiPathways |
B_2_1 |
WP2059 |
Alzheimer 39 s disease and miRNA effects |
3/13 |
268/8836 |
0.00629648143855259 |
0.0204635646752959 |
0.00994181279771461 |
HSD17B10/PSMA5/PSMB3 |
3 |